Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T77365 | Target Info | |||
Target Name | Adenosine A2a receptor (ADORA2A) | ||||
Synonyms | Adenosine receptor A2a; ADORA2; A2a Adenosine receptor; A(2A) adenosine receptor | ||||
Target Type | Successful Target | ||||
Gene Name | ADORA2A | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Stearic acid | Ligand Info | |||
Canonical SMILES | CCCCCCCCCCCCCCCCCC(=O)O | ||||
InChI | 1S/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20) | ||||
InChIKey | QIQXTHQIDYTFRH-UHFFFAOYSA-N | ||||
PubChem Compound ID | 5281 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 3EML The 2.6 A Crystal Structure of a Human A2A Adenosine Receptor bound to ZM241385. | ||||||
Method | X-ray diffraction | Resolution | 2.60 Å | Mutation | No | [1] |
PDB Sequence |
IMGSSVYITV
12 ELAIAVLAIL22 GNVLVCWAVW32 LNSNLQNVTN42 YFVVSLAAAD52 IAVGVLAIPF 62 AITISTGFCA72 ACHGCLFIAC82 FVLVLTQSSI92 FSLLAIAIDR102 YIAIRIPLRY 112 NGLVTGTRAK122 GIIAICWVLS132 FAIGLTPMLG142 WNNCGQSQGC159 GEGQVACLFE 169 DVVPMNYMVY179 FNFFACVLVP189 LLLMLGVYLR199 IFLAARRQLN1002 IFEMLRIDEG 1012 LRLKIYKDTE1022 GYYTIGIGHL1032 LTKSPSLNAA1042 KSELDKAIGR1052 NTNGVITKDE 1062 AEKLFNQDVD1072 AAVRGILRNA1082 KLKPVYDSLD1092 AVRRAALINM1102 VFQMGETGVA 1112 GFTNSLRMLQ1122 QKRWDEAAVN1132 LAKSRWYNQT1142 PNRAKRVITT1152 FRTGTWDAYR 222 STLQKEVHAA232 KSLAIIVGLF242 ALCWLPLHII252 NCFTFFCPDC262 SHAPLWLMYL 272 AIVLSHTNSV282 VNPFIYAYRI292 REFRQTFRKI302 IRSHVLRQ
|
|||||
|
LEU19
4.932
ILE21
4.952
LEU22
4.141
GLY23
3.692
VAL25
4.503
LEU26
4.452
CYS28
4.124
TRP29
4.085
TRP32
3.841
TYR43
4.052
VAL46
3.502
SER47
4.343
ALA50
3.757
ILE53
4.013
ALA54
4.171
GLY56
4.678
VAL57
3.138
LEU58
3.656
PRO61
4.065
PHE62
3.490
THR65
3.817
|
|||||
PDB ID: 3VG9 Crystal structure of human adenosine A2A receptor with an allosteric inverse-agonist antibody at 2.7 A resolution | ||||||
Method | X-ray diffraction | Resolution | 2.70 Å | Mutation | Yes | [2] |
PDB Sequence |
SSVYITVELA
15 IAVLAILGNV25 LVCWAVWLNS35 NLQNVTNYFV45 VSLAAADIAV55 GVLAIPFAIT 65 ISTGFCAACH75 GCLFIACFVL85 VLTQSSIFSL95 LAIAIDRYIA105 IRIPLRYNGL 115 VTGTRAKGII125 AICWVLSFAI135 GLTPMLGWNN145 CGQSQGCGEG162 QVACLFEDVV 172 PMNYMVYFNF182 FACVLVPLLL192 MLGVYLRIFL202 AARRQLKQME212 SQPLPGERAR 222 STLQKEVHAA232 KSLAIIVGLF242 ALCWLPLHII252 NCFTFFCPDC262 SHAPLWLMYL 272 AIVLSHTNSV282 VNPFIYAYRI292 REFRQTFRKI302 IRSHVLR
|
|||||
|
VAL25
4.639
CYS28
3.273
TRP29
3.725
VAL31
4.270
TRP32
3.024
GLN38
3.736
TYR43
3.402
VAL46
3.758
ALA50
4.493
TYR103
3.152
TRP129
3.168
PHE133
3.956
PHE182
3.887
LEU187
4.766
LEU190
3.686
LEU191
3.462
LEU192
3.817
LEU194
3.556
GLY195
3.908
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science. 2008 Nov 21;322(5905):1211-7. | ||||
REF 2 | G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody. Nature. 2012 Jan 29;482(7384):237-40. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.